---
name: Abzena
slug: abzena
site: both
website_domain: abzena.com
summary: Fully integrated biologics and bioconjugates CDMO+CRO offering drug design, development, and GMP manufacturing for antibodies, ADCs, AOCs, RDCs, and vaccines from discovery through commercial scale. Headquartered in San Diego, United States.
tagline: Fully integrated biologics & bioconjugates CDMO+CRO from discovery to commercial.
founded_year: 
employee_count_band: 
employee_count_label: 
parent_name: 
parent_slug: 
hq_country: US
tier2_domain_verified: false
updated_at: 2026-06-28T07:00:57.615Z
services_count: 13
modalities_count: 3
indications_count: 0
locations_count: 4
review_signal_gate: closed
generated_by: BioBM Editorial AI
---

# Abzena

Fully integrated biologics & bioconjugates CDMO+CRO from discovery to commercial.

Listed on cro.directory.

## Summary

Fully integrated biologics and bioconjugates CDMO+CRO offering drug design, development, and GMP manufacturing for antibodies, ADCs, AOCs, RDCs, and vaccines from discovery through commercial scale. Headquartered in San Diego, United States.

## At a glance

- HQ country: US

## Services

- CMC Analytical Development
- Cell-Line Development
- Process Development
- Technology Transfer
- Quality Control Testing
- Stability Testing & Storage
- CMC Regulatory Submission Support
- ADC (Antibody-Drug Conjugate) Manufacturing
- ADC Payload & Linker Synthesis
- Bioconjugation Services
- Monoclonal Antibody (mAb) Manufacturing
- Recombinant Protein Manufacturing
- Biologics Development & Manufacturing

## Modalities

- Biologics (Monoclonal Antibodies)
- Antibody-Drug Conjugate (ADC)
- Biologics (Other)

## Locations

- San Diego, San Diego, California, USA
- Cambridge, Cambridge, England, UK
- Raleigh, Raleigh, North Carolina, USA
- Bristol, Bristol, Connecticut, USA

## Long description

Abzena is a fully integrated biopharmaceutical CDMO and CRO specializing in biologics and bioconjugates. The company provides tailored drug design, development, and GMP manufacturing services across the full product lifecycle—from discovery through commercial manufacturing.

**Core Capabilities:**

- **Biologics:** Antibody engineering, protein and antibody expression, cell line development, master cell banking, process development and optimization, clinical and commercial manufacturing, quality control and stability testing, analytical method development, and bioassays.
- **Bioconjugates & ADCs:** Design and synthesis of linker-payloads, ADC manufacturing, antibody-oligonucleotide conjugates (AOCs), radionuclide drug conjugates (RDCs), process track record, process performance qualification (PPQ), and handling of highly potent materials.
- **Analytics & Immunogenicity:** Surface plasmon resonance (SPR), early-phase bioassays, immunogenicity assays (EpiScreen T-cell epitope mapping, MAPPS, time-course T-cell assays, cytokine screens, custom immunology assays), and ITOPE/TCED.
- **Integrated Programs:** HIT-to-lead, IND/BLA, DNA-IND-CTA, and developability assessment.
- **Proprietary Solutions:** AbzelectPro, Labzient, ThioBridge, and composite protein/antibody platforms.

Abzena deploys best-in-class biologic development technologies, shortens lead times, and implements risk mitigation strategies to accelerate time-to-clinic and commercial launch.

_Profile last updated: 2026-06-28T07:00:57.615Z. Profile facts may include AI-assisted enrichment._

Auto-generated by BioBM Editorial AI for machine-readable profile access.